NCT00572091View on ClinicalTrials.gov

Aachen Safety and Efficacy of the Percutaneous Transvenous Mitral Annuloplasty Device to Reduce Mitral Regurgitation

PHASE1/PHASE2CompletedINTERVENTIONAL
Enrollment

4

Participants

Timeline

Start Date

February 28, 2007

Primary Completion Date

April 30, 2008

Study Completion Date

November 30, 2008

Conditions
Heart FailureMitral Regurgitation
Interventions
DEVICE

PTMA Implant

Percutaneous assessment from right or left subclavian vein, with PTMA implant in the coronary sinus, great cardiac vein.

Trial Locations (1)

D-52057

Rheinisch-Westfalische Technische Hochschule, Universitätsklinikum Aachen, Aachen

All Listed Sponsors
lead

Viacor

INDUSTRY

NCT00572091 - Aachen Safety and Efficacy of the Percutaneous Transvenous Mitral Annuloplasty Device to Reduce Mitral Regurgitation | Biotech Hunter | Biotech Hunter